ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;85:494-500. doi:10.1016/j.athoracsur.2007.10.008
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mitchell J. Magee
John H. Alexander
T. Bruce Ferguson, Jr
Eric D. Peterson
Nicholas T. Kouchoukos
Michael J. Mack
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magee, M. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Magee, M. J.
Related Collections
Right arrow Coronary disease


Original Articles: Cardiovascular

Coronary Artery Bypass Graft Failure After On-Pump and Off-Pump Coronary Artery Bypass: Findings From PREVENT IV

Mitchell J. Magee, MDa,g,*, John H. Alexander, MD, MHSb, Gail Hafley, MSc, T. Bruce Ferguson, Jr, MDd, C. Michael Gibson, MDe, Robert A. Harrington, MDb, Eric D. Peterson, MD, MPHb, Robert M. Califf, MDb, Nicholas T. Kouchoukos, MDf, Morley A. Herbert, PhDg, Michael J. Mack, MDa,f PREVENT IV Investigators

a Cardiopulmonary Research Science and Technology Institute, Dallas, Texas
b Duke University Medical Center, Durham, North Carolina
c Duke Clinical Research Institute, Durham, North Carolina
d East Carolina Cardiovascular Institute, Greenville, North Carolina
e PERFUSE Angiographic Core Laboratory, Boston, Massachusetts
f Missouri Baptist Medical Center, St. Louis, Missouri
g Medical City Dallas Hospital, Dallas, Texas

Accepted for publication October 2, 2007.

* Address correspondence to Dr Magee, Medical City Dallas Hospital, 7777 Forest Lane, Ste A323, Dallas, TX 75230 (Email: mmagee{at}csant.com).

Presented at the Fifty-third Annual Meeting of the Southern Thoracic Surgical Association, Tucson, AZ, Nov 8–11, 2006.

Background: This analysis compares 1-year vein graft patency and major adverse cardiac and cerebral events (MACCE [death, myocardial infarction, or stroke]) in on-pump and off-pump patients enrolled in PREVENT IV (the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV).

Methods: The PREVENT IV was a multicenter (107 sites) randomized trial of edifoligide to prevent vein graft failure from neointimal hyperplasia in 3,014 patients undergoing primary, isolated coronary artery bypass grafting (CABG) with at least two vein grafts. One-year angiographic follow-up was completed on 1,920 patients (4,736 grafts) with MACCE follow-up on 99.4% of enrolled patients.

Results: In all, 2,377 procedures (78.9%) were on pump and 637 (21.1%) were off pump. On-pump patients had more chronic lung disease (17% versus 11%; p < 0.001), congestive heart failure (10% versus 7%; p = 0.03), lower mean ejection fraction (50% versus 55%; p < 0.001), and worse target artery quality (good 63.8% versus 68.1%; fair 26.4% versus 22.7%; poor 9.8% versus 9.2%; p < 0.001). Vein graft failure (more than 75% graft stenosis) in on- versus off-pump patients was 25.3% versus 25.7% (p = 0.62). After adjusting for differences in significant predictors of vein graft failure (target artery quality, surgery time, endoscopic vein harvest, more than 1 distal anastomosis/graft, and patient weight), the odds of vein graft failure was 0.82 (95% confidence interval: 0.67 to 1.00; p = 0.05) for on-pump versus off-pump patients. One-year mortality for on- versus off-pump patients was 3.3% versus 2.5% (p = 0.30); and MACCE was 15.4% versus 11.3% (p = 0.01). The adjusted hazard ratio for 1-year MACCE was 1.31 (95% confidence interval: 1.01–1.69; p = 0.01) for on pump versus off pump.

Conclusions: Observed saphenous vein failure rate was 25% in both groups. One-year clinical outcomes (MACCE) were better with off-pump than with on-pump CABG, suggesting benefits not related to vein graft patency.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
D. M. Holzhey, S. Jacobs, M. Mochalski, D. Merk, T. Walther, F. W. Mohr, and V. Falk
Minimally Invasive Hybrid Coronary Artery Revascularization.
Ann. Thorac. Surg., December 1, 2008; 86(6): 1856 - 1860.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
J. G. Byrne, M. Leacche, D. E. Vaughan, and D. X. Zhao
Hybrid Cardiovascular Procedures
J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 459 - 468.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.